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Association of oral lichen planus
with thyroid disease in a Finnish
population: A retrospective case-
control study: “A different finding
from a Mediterranean area”
To the Editor:
Siponen et al.1 report an association of oral lichen
planus/oral lichenoid lesions (OLP/OLL) with thyroid
disease in the Finnish population. As they point out,
OLP has been associated with a number of systemic
disorders, generally of autoimmune origin (myasthenia
gravis, Sjögren’s syndrome, ulcerative colitis, psoria-
sis, celiac disease, some liver diseases, thymoma, and
lupus erythematosus); however, only in a few condi-
tions has this link been confirmed.2-6 For example, the
correlation between chronic hepatitis C virus (HCV)
infection and OLP would be one of these, even if many
contrasting results have been published,7-14 and the
partial dependency on geographic factors as well as
genetic differences has been focused.15,16 Furthermore,autoimmune conditions, such as systemic lupus ery-
thematosus, rheumatoid arthritis, and celiac disease
have also been simply found to be associated with
autoimmune thyroid diseases,17 but without great and
definitive evidence.
Hence, the association between OLP/OLL and thy-
roid diseases/thyroid medication, in particular hypothy-
roidism, have been reported in some studies18-20 up to
the recent study by Siponen et al.,1 who analyzed
retrospectively 222 OLP/OLL patients and 222 con-
trols, with a marginal significant association (95% con-
fidence interval [CI]  1.03 to 4.90) between OLP/
OLL and hypothyroidism (10% versus 5% in controls).
Finally, the authors suggested that the association of
OLP and hypothyroidism could be linked to a similar,
but still unknown, immune-mediated mechanism, war-
ranting further studies in a different population.
With this regard, we would like to share our findings
from a cross-sectional study performed in Sicily (West
Mediterranean area). We consecutively recruited 125
resident patients, of these 74 had Hashimoto’s thyroid-
itis or Graves disease (70 female and 4 male; mean age:
47  15.2 years; range: 14 to 79 years; of which 58
patients had Hashimoto’s thyroiditis and 16 had Graves
disease) as the test group; these 2 autoimmune pathol-
ogies share with OLP a common immune-mediated
pathogenesis, causing hypothyroidism and hyperthy-
roidism, respectively. Controls were 51 patients (42
female; 9 male; mean age: 54.6 11.5 years; range: 24
to 73 years) suffering from goiter, an endemic disease
in Sicily without autoimmune pathogenesis,21 and were
found to be matched for age and gender with the test
group (P  .2 by Student t).
In all samples, thyroid diseases were diagnosed
both serologically and histologically; all patients un-
derwent total thyroidectomy and subsequent replace-
ment with thyroxin medication. All patients under-
went oral examination, independently, by 2 of the
authors (C.D. and C. P.), both experts in oral medi-
cine. In our study, all patients who were HCV-
positive or with OLL potentially associated with
drugs,22 amalgam fillings, or topical allergens were
excluded, different from Siponen et al.,1 to reduce
biases on the final results.
One patient with Hashimoto’s thyroiditis showed
oral lesions with a reticular aspect bilaterally on the
buccal mucosa and atrophic/erosive features on the
masticatory mucosa, compatible with the diagnosis of
OLP. The patient underwent incisional oral biopsy and
the subsequent histologic examination confirmed the
diagnosis of OLP. None of the controls showed clinical
signs of OLP/OLL.
Different from Siponen et al.,1 we did not find any
significant association between autoimmune thyroid
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OLL, presumptively high because of the endemic status
of thyroid diseases in our population and the conse-
quent use of thyroxine-based drugs.
In conclusion, with regard to the findings by Siponen
et al.,1 we do not think that the data to date show
definitively an association between OLP/OLL and, at
least, hypothyroidism, especially with the potential for
biases from sample size calculation and consequently
from type I error.
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In reply:
We thank Dr Compilato et al. for their interest in our
study and for sharing their own findings. We also fully
agree with their statement “. . . we do not think the data
to date show definitively an association between OLP/
OLL and, at least, hypothyroidism” up to this point.
Nothing in our article indicates a different conclusion;
yet, we are unable to follow their argument to the end.
For example, the meaning of “bias from sample size
calculation” remains obscure to us, such a bias not
being described in any well-known textbook on epide-
miologic methods. Therefore, we would like to elabo-
rate some methodological issues that we consider es-
sential when evaluating observational evidence
provided either by any single study, including theirs
and ours, or jointly by several independent studies on
the same question.
A major problem encountered in any epidemiologic
study addressing the existence, direction, and strength
of a conceivable association between thyroid diseases
